Written By Bill Sardi
October 2014

                  In a revealing report entitled “Ebola is in America – And, Finally, Within Range Of Big Pharma,” the London-based Guardian newspaper tells how the battle against Ebola was pre-planned. (Guardian UK Oct 4, 2014)

It appears an effort to drum up an Ebola virus crisis emanated from publication of a list of neglected diseases by the World Health Organization (WHO) in 2012. With the publication of that list, 13 pharmaceutical companies teamed up with the WHO and the Gates Foundation to control or eradicate ten diseases like tuberculosis, river blindness, sleeping sickness and Ebola.

The “End Neglected Tropical Diseases Act” introduced in Congress this year calls for the United States to expand its disease-fighting activities to address international tropical diseases.

Investment houses are paying attention. “Ebola could be the issue that sends the whole thing snowballing. You are going to get more industry engagement. The signs were already positive after the London Declaration on neglected tropic diseases in 2012,” said a Deutsche Bank analyst. Commercial interests, not disease, are the driving force behind this epidemic.

That analyst also said: “To the extent that these diseases are starting to appear in the U.S., this will put the issue much more firmly on US companies’ radar.” Is this why the arrival of a single case of Ebola involving an airline traveler to the U.S. is getting so much attention?

Once U.S. citizens’ lives are threatened this will justify use of U.S. funds to develop drugs and vaccines that poor countries cannot afford and also pawn the cost of human studies onto the American public rather than pharmaceutical or vaccine makers. This will save billions of research and development dollars for the vaccine and drug companies.

And apparently both sides will profit. It is difficult to fathom that agencies purported to promote public health hold patents on varieties of deadly viruses like Ebola. (US Patent publication number US20120251502A1) One begins to wonder what business these public agencies are in – profiteering or health?

So the unprecedented Ebola virus outbreak occurs right on time, based upon questionable diagnostic tests to count up the numbers needed to gain World attention.

Moreover, an article in Forbes magazine says the Ebola epidemic has silenced critics of Big Pharma, especially “innovator” drug companies that have been criticized for using patents to produce over-priced drugs beyond the affordability of many countries with exotic tropical diseases.

Now, says the Forbes article, “with the tragic outbreak and ominous spread of the Ebola virus, the whole world seems to be knocking at the drug companies’ doors hoping they will devise some way to prevent or cure Ebola.” (Forbes.com Sept 11, 2014) But has the whole Ebola epidemic simply been contrived?

Unsurprisingly, Ebola virus and the whole class of filoviruses (which includes the Marburg virus) are characterized as potential bioweapons making the list of the CDC’s Category-A Bioterrorism Agents.

Ebola is described as being “relatively stable in aerosols” and can remain present on surfaces for extended periods of time. Tests were performed on monkeys to show that aerosolized Ebola, especially under low temperature and humid conditions, can result in increased body temperatures (a fever) beginning 4-5 days following initial exposure. This shocking report shows that infectious-disease experts have already pre-tested Ebola as a bioweapon – and here is the key part of the report – “as a foundation for testing vaccines and therapeutics.”

The tests were conducted in 2012 by investigators at the U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, the very same bioweapons center where an engineered anthrax bacterium was genetically traced back to in the crisis following the 9-11 terrorist attacks. (Viruses Oct 15, 2012)

Interestingly, two drug/vaccine makers developing therapeutic agents against the Ebola virus receive funding, not from the Centers for Disease Control, not from the National Institutes of Health, not from the WHO, but from the U.S. Department of Defense, which has pre-tested Ebola in the animal lab as a terrorist bioweapon, not as a preventive vaccine. (CDC August 29, 2014)

In an outspoken article written by Dr. Cyril Broderick, a former professor of plant pathology at the University of Liberia’s College of Agriculture, and published in The Liberian Observer, the pharmaceutical industry and the U.S. Department of Defense are fingered as conspirators in a plot to intentionally spread Ebola to provoke public demand to use unproven vaccines and drug as rescue remedies.

Professor Broderick notes reports that the U.S. Department of Defense funded Ebola trials on humans just prior to the Ebola outbreak in Guinea and Sierra Leone. In his letter addressed to all “world citizens,” Professor Broderick pleads for everyone to “please stand up to stop Ebola testing and the spread of this dastardly disease.” (Liberian Observer, Sept 9, 2014)

In short, the widely reported Ebola outbreak is overstated by health authorities and the news media. Malnutrition largely explains why Ebola virus has remained uniquely confined to central and western Africa. If Ebola escapes to other well-fed regions of the World, it can only be sustained among those individuals who are immune compromised (smokers, diabetics, alcohol and drug abusers, immune suppressive drug users, infants and the very old).

If there is some sinister plot to intentionally expose the U.S. population or any other human population for that matter to weaponized Ebola virus, it will likely be foiled by good nutrition.   Nutrition is to Big Pharma what a ring of garlic cloves is to Dracula.

The only entity that has advanced technology to spread Ebola is the U.S. Department of Defense, not some Third-World bio-terrorist. And that is exactly where the anthrax bacterium was traced to in the aftermath of the 9-11 terrorist attacks.

Whether covert government operations exist to intentionally expose the American population to biological threats to put counter terrorist operations to the test will likely never be revealed. Whatever is going on, a giant mind-control operation is currently underway as the current Ebola crisis is a massive fabrication on a worldwide scale.

According to surveys, there is a growing body of Americans who believe that an Ebola attack is coming to America. The question is whether Americans will fall for the idea that some lone terrorist inside some biological lab is capable of such a feat or whether a more sinister operation is underway by parties working on a larger scale. The current evidence points in the latter direction. As the late Dr. Stan Monteith frequently said: “America has the best enemies money can buy.” Can Americans face that truth? Maybe this time they can’t avoid it.

Read the full article at: www.thenhf.com/______.

© 2014 Bill Sardi, Knowledge of Health, Inc.